NCT00948987View on ClinicalTrials.gov

Mechanism Based Resistance to Aspirin

PHASE1CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Aspirin ResistancePharmacological Aspirin Non-responsiveness
Interventions
DRUG

Aspirin

325 mg enteric coated single dose p.o.

Sponsors

Collaborators (1)

Bayer
All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

Bayer

INDUSTRY

lead

University of Pennsylvania

OTHER

NCT00948987 - Mechanism Based Resistance to Aspirin | Biotech Hunter | Biotech Hunter